| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2893.1996.TB00084.X |
| P8608 | Fatcat ID | release_mabgp6iinverjomo63tghb6xxa |
| P698 | PubMed publication ID | 8811641 |
| P2093 | author name string | McHutchison JG | |
| Nguyen TT | |||
| Pockros PJ | |||
| Lindsay KL | |||
| Sedghi-Vaziri A | |||
| Mondala T | |||
| Wilkes LB | |||
| P2860 | cites work | Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C. | Q43041128 |
| Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients | Q43049083 | ||
| Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. | Q43049490 | ||
| Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival | Q46641624 | ||
| P433 | issue | 2 | |
| P921 | main subject | viral load | Q2528140 |
| P304 | page(s) | 75-78 | |
| P577 | publication date | 1996-03-01 | |
| P1433 | published in | Journal of Viral Hepatitis | Q15749962 |
| P1476 | title | Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection | |
| P478 | volume | 3 |
| Q38183312 | Acute hepatitis C: management in the rapidly evolving world of HCV. |
| Q37805839 | Adaptive Immunity to the Hepatitis C Virus |
| Q39573613 | African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians |
| Q36375990 | Analytical and biological variables influencing quantitative hepatitis C virus (HCV) measurement in HIV-HCV coinfection |
| Q27469406 | Assessment of Spontaneous Fluctuations of Viral Load in Untreated Patients with Chronic Hepatitis C by Two Standardized Quantitation Methods: Branched DNA and Amplicor Monitor |
| Q41712075 | Biological dynamics of viral load in hemodialysis patients with hepatitis C virus |
| Q41351156 | Branched DNA for quantification of viral load |
| Q45015662 | Case report: effect of antileishmanial treatment on hepatitis C viraemia in a visceral leishmaniasis patient with chronic hepatitis C. |
| Q45722781 | Changes in viremia and circulating interferon-alpha during hemodialysis in hepatitis C virus-positive patients: only coincidental phenomena? |
| Q35960902 | Clinical application of hepatitis C virus genotyping and quantitation |
| Q27477946 | Clinical guidelines on the management of hepatitis C |
| Q33809452 | Clinical implications of hepatitis C viral kinetics |
| Q34210668 | Clinical use of hepatitis C virus tests for diagnosis and monitoring during therapy |
| Q42997645 | Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. |
| Q34098835 | Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring |
| Q27469997 | Dynamics of Persistent TT Virus Infection, as Determined in Patients Treated with Alpha Interferon for Concomitant Hepatitis C Virus Infection |
| Q42989435 | Effect of ribavirin on virus load and quasispecies distribution in patients infected with hepatitis C virus |
| Q27480999 | Factors Affecting Serum Concentrations of Hepatitis C Virus (HCV) RNA in HCV Genotype 1-Infected Patients with Chronic Hepatitis |
| Q43036608 | Fluctuation of serum HCV-RNA levels in untreated blood donors with chronic hepatitis C virus infection |
| Q42994719 | Fluctuations of hepatitis C virus load are not related to amino acid substitutions in hypervariable region 1 and interferon sensitivity determining region |
| Q34769764 | Fluvastatin inhibits hepatitis C replication in humans |
| Q42978412 | HCV replication and statin pleotropism: an adjuvant treatment panacea? |
| Q27860724 | Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy |
| Q37060801 | Hepatitis C Viral Kinetics in Special Populations |
| Q35610571 | Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and IL28B. |
| Q34210699 | Hepatitis C viral dynamics |
| Q35017798 | Hepatitis C viral dynamics: basic concept and clinical significance |
| Q42991828 | Hepatitis C virus RNA profiles in chronically infected individuals: do they relate to disease activity? |
| Q43042041 | Hepatitis C virus RNA quantitation in hepatic veins and peripheral blood in patients with liver cirrhosis: evidence for low level intrahepatic hepatitis C virus replication in advanced liver disease |
| Q34121125 | Hepatitis C virus carriers with persistently normal aminotransferase levels: healthy people or true patients? |
| Q33735212 | Hepatitis C virus reactivation in cancer patients in the era of targeted therapies. |
| Q27489594 | Improving the Diagnosis of Acute Hepatitis C Virus Infection with Expanded Viral Load Criteria |
| Q26752471 | KASL clinical practice guidelines: management of hepatitis C |
| Q51836024 | KASL clinical practice guidelines: management of hepatitis C. |
| Q43039777 | Long-term patterns of hepatitis C virus RNA concentrations in a cohort of HIV seronegative men with bleeding disorders |
| Q42995852 | Low HCV replication levels in end-stage hepatitis C virus-related liver disease |
| Q27488804 | Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon |
| Q59881480 | Natural fluctuations of hepatitis C viral load in a homogeneous patient population: A prospective study |
| Q36263215 | New kinetic models for the hepatitis C virus |
| Q40463230 | Novel symmetrical phenylenediamines as potential anti-hepatitis C virus agents. |
| Q33394547 | Pathobiology and Treatment of Hepatitis Virus-Related Thrombocytopenia |
| Q42979944 | Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology |
| Q28481414 | Pioglitazone Decreases Hepatitis C Viral Load in Overweight, Treatment Naïve, Genotype 4 Infected-Patients: A Pilot Study |
| Q42987319 | Quantification of the initial decline of serum hepatitis c virus RNA and response to interferon alfa |
| Q42990986 | Sequential serum hepatitis C viral RNA levels longitudinally assessed by branched DNA signal amplification |
| Q36900065 | Shedding of Hepatitis C Virus in Semen of Human Immunodeficiency Virus-Infected Men. |
| Q42545300 | The effect of alanine aminotransferase dynamics on predicting sustained virological response in chronic hepatitis C virus infection |
| Q34422746 | The kinetics of hepatitis C virus infection |
| Q35362239 | The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985 |
| Q34478761 | Treatment of Chronic Hepatitis C: Lessons from Human Immunodeficiency Virus Dynamics |
| Q42837685 | Understanding the nature of early HCV RNA blips and the use of mathematical modeling of viral kinetics during IFN-based therapy |
| Q35960876 | Use and interpretation of HCV diagnostic tests in the clinical setting |
| Q34984049 | Use and interpretation of virological tests for hepatitis C. |
| Q42997091 | Viral kinetics and mathematical models |
Search more.